Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6010771 | 1.00 | CHRM1 (0.33) | CHRM1KCNH2 | |
| SCHEMBL6010863 | 1.00 | CHRM1 (0.33) | CHRM1KCNH2 | |
| SCHEMBL5540324 | 0.84 | CHRM1 (0.35) | CHRM1KCNH2 | |
| SCHEMBL5538961 | 0.84 | CHRM1 (0.35) | CHRM1KCNH2 | |
| SCHEMBL5538952 | 0.84 | CHRM1 (0.35) | CHRM1KCNH2 | |
| SCHEMBL6010597 | 0.80 | KCNH2 (0.46) | CHRM1KCNH2 | |
| SCHEMBL6010604 | 0.80 | KCNH2 (0.46) | CHRM1KCNH2 | |
| SCHEMBL6010669 | 0.80 | KCNH2 (0.46) | CHRM1KCNH2 | |
| SCHEMBL6010751 | 0.79 | CHRM1 (0.38) | CHRM1KCNH2 | |
| SCHEMBL6010758 | 0.79 | CHRM1 (0.38) | CHRM1KCNH2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20060094767-A1 | 2,3-Dihydro-6-nitroimidazo[2,1-b]oxazoles | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2006-05-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060094767-A1 | 2,3-Dihydro-6-nitroimidazo[2,1-b]oxazoles | NR2C2, NR4A3, NR4A2 | CHRM1 463/4885KCNH2 3503/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.